Chronic pulmonary disease
Conditions
Interventions
Group A:Use ANORO with Zheng's inhalation method of aerosol
Group B:Use ANORO with conventional inhalation method (recommended in the drug manual)
Group C:Control group without ANORO inhalation
Sponsors
The First Affiliated Hospital of Guangzhou Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Disease diagnostic criteria in line with the 2020 GOLD guideline; 2. First use of olexin inhalation device; 3. Be able to complete various operations and tests of this study; 4. After treatment, the patient's condition was stable, and was about to leave the hospital.
Exclusion criteria
Exclusion criteria: 1. Those who have hypoxemia and need continuous oxygen inhalation; 2. Besides COPD, there are other diseases that affect drug use; 3. Diseases that are allergic to ANORO or have obvious side effects after use; 4. Patients with severe milk protein allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6 minutes walk test;3-minute aerial treadmills steps (3MATS);Modified Medical Research Council Dyspnea Scale;Heart rate;Respiratory rate;Blood oxygen; | — |
Secondary
| Measure | Time frame |
|---|---|
| Training time for inhalation methods;The number of demonstrations of inhalation methods;The patient's preference for the device; | — |
Countries
China
Contacts
Public ContactZeguang Zheng
The First Affiliated Hospital of Guangzhou Medical University
Outcome results
None listed